PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)

PHASE1TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 8, 2016

Primary Completion Date

January 26, 2021

Study Completion Date

January 26, 2021

Conditions
Solid TumorsNHL
Interventions
DRUG

KPT-9274

DRUG

Niacin ER

DRUG

Nivolumab

Trial Locations (8)

20007

Georgetown University, Lombardi Comprehensive Cancer Center, Washington D.C.

37232

Vanderbilt-Ingram Cancer Center, Nashville

55905

Mayo Clinic Rochester, Rochester

77030

MD Anderson Cancer Center, Houston

80045

University of Colorado Cancer Center, Aurora

90024

UCLA Health, Los Angeles

100016

NYU-Laura & Isaac Perlmutter Cancer Center, New York

M5G 2M9

Princess Margaret Hospital, Toronto

Sponsors
All Listed Sponsors
lead

Karyopharm Therapeutics Inc

INDUSTRY